First Time Loading...

Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 91.645 USD 0.32% Market Closed
Updated: Apr 16, 2024

Intrinsic Value

Amedisys, Inc. engages in the provision of healthcare services. [ Read More ]

The intrinsic value of one AMED stock under the Base Case scenario is 103.314 USD. Compared to the current market price of 91.645 USD, Amedisys Inc is Undervalued by 11%.

Key Points:
AMED Intrinsic Value
Base Case
103.314 USD
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Amedisys Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AMED stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Amedisys Inc

Provide an overview of the primary business activities
of Amedisys Inc.

What unique competitive advantages
does Amedisys Inc hold over its rivals?

What risks and challenges
does Amedisys Inc face in the near future?

Has there been any significant insider trading activity
in Amedisys Inc recently?

Summarize the latest earnings call
of Amedisys Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amedisys Inc.

Provide P/S
for Amedisys Inc.

Provide P/E
for Amedisys Inc.

Provide P/OCF
for Amedisys Inc.

Provide P/FCFE
for Amedisys Inc.

Provide P/B
for Amedisys Inc.

Provide EV/S
for Amedisys Inc.

Provide EV/GP
for Amedisys Inc.

Provide EV/EBITDA
for Amedisys Inc.

Provide EV/EBIT
for Amedisys Inc.

Provide EV/OCF
for Amedisys Inc.

Provide EV/FCFF
for Amedisys Inc.

Provide EV/IC
for Amedisys Inc.

Show me price targets
for Amedisys Inc made by professional analysts.

What are the Revenue projections
for Amedisys Inc?

How accurate were the past Revenue estimates
for Amedisys Inc?

What are the Net Income projections
for Amedisys Inc?

How accurate were the past Net Income estimates
for Amedisys Inc?

What are the EPS projections
for Amedisys Inc?

How accurate were the past EPS estimates
for Amedisys Inc?

What are the EBIT projections
for Amedisys Inc?

How accurate were the past EBIT estimates
for Amedisys Inc?

Compare the revenue forecasts
for Amedisys Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amedisys Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amedisys Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amedisys Inc compared to its peers.

Compare the P/E ratios
of Amedisys Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Amedisys Inc with its peers.

Analyze the financial leverage
of Amedisys Inc compared to its main competitors.

Show all profitability ratios
for Amedisys Inc.

Provide ROE
for Amedisys Inc.

Provide ROA
for Amedisys Inc.

Provide ROIC
for Amedisys Inc.

Provide ROCE
for Amedisys Inc.

Provide Gross Margin
for Amedisys Inc.

Provide Operating Margin
for Amedisys Inc.

Provide Net Margin
for Amedisys Inc.

Provide FCF Margin
for Amedisys Inc.

Show all solvency ratios
for Amedisys Inc.

Provide D/E Ratio
for Amedisys Inc.

Provide D/A Ratio
for Amedisys Inc.

Provide Interest Coverage Ratio
for Amedisys Inc.

Provide Altman Z-Score Ratio
for Amedisys Inc.

Provide Quick Ratio
for Amedisys Inc.

Provide Current Ratio
for Amedisys Inc.

Provide Cash Ratio
for Amedisys Inc.

What is the historical Revenue growth
over the last 5 years for Amedisys Inc?

What is the historical Net Income growth
over the last 5 years for Amedisys Inc?

What is the current Free Cash Flow
of Amedisys Inc?

AI Assistant can make mistakes. Consider checking important information.
Financials

Balance Sheet Decomposition
Amedisys Inc

Current Assets 496.9m
Cash & Short-Term Investments 126.5m
Receivables 313.4m
Other Current Assets 57.1m
Non-Current Assets 1.6B
Long-Term Investments 66.1m
PP&E 130.8m
Intangibles 1.3B
Other Non-Current Assets 19m
Current Liabilities 473.7m
Accounts Payable 28.2m
Accrued Liabilities 303.2m
Other Current Liabilities 142.3m
Non-Current Liabilities 519.9m
Long-Term Debt 361.9m
Other Non-Current Liabilities 158.1m
Efficiency

Earnings Waterfall
Amedisys Inc

Revenue
2.2B USD
Cost of Revenue
-1.2B USD
Gross Profit
990.9m USD
Operating Expenses
-797.8m USD
Operating Income
193.1m USD
Other Expenses
-202.8m USD
Net Income
-9.7m USD

Free Cash Flow Analysis
Amedisys Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AMED Profitability Score
Profitability Due Diligence

Amedisys Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
49/100
Profitability
Score

Amedisys Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

AMED Solvency Score
Solvency Due Diligence

Amedisys Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
54/100
Solvency
Score

Amedisys Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMED Price Targets Summary
Amedisys Inc

Wall Street analysts forecast AMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMED is 99.733 USD with a low forecast of 73.73 USD and a high forecast of 106.05 USD.

Lowest
Price Target
73.73 USD
20% Downside
Average
Price Target
99.733 USD
9% Upside
Highest
Price Target
106.05 USD
16% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AMED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AMED Price
Amedisys Inc

1M 1M
-2%
6M 6M
-1%
1Y 1Y
+16%
3Y 3Y
-68%
5Y 5Y
-21%
10Y 10Y
+567%
Annual Price Range
91.645
52w Low
73.99
52w High
95.9
Price Metrics
Average Annual Return 6.38%
Standard Deviation of Annual Returns 61.89%
Max Drawdown -78%
Shares Statistics
Market Capitalization 3B USD
Shares Outstanding 32 667 600
Percentage of Shares Shorted 8.9%

AMED Return Decomposition
Main factors of price return

What is price return decomposition?

AMED News

Other Videos

Last Important Events
Amedisys Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Amedisys Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Amedisys Inc Logo
Amedisys Inc

Country

United States of America

Industry

Health Care

Market Cap

3B USD

Dividend Yield

0%

Description

Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.

Contact

LOUISIANA
Baton Rouge
3854 American Way Ste A
+12252922031.0
https://www.amedisys.com/

IPO

1994-08-17

Employees

21 000

Officers

Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Chief Information Officer
Mr. Michael P. North
Chief Compliance Officer
Ms. Denise Bohnert
Chief Strategy Officer
Mr. Nick Muscato
President, CEO & Director
Mr. Richard M. Ashworth
Chief Accounting Officer & Principal Accounting Officer
Ms. Allyson Guidroz
Show More
CTO & Senior VP of Business Operations Systems
Mr. Pete Hartley
Senior VP, Deputy General Counsel, Corporate Secretary & Interim Chief Legal Officer
Ms. Jennifer Guckert Griffin
VP of Marketing & Communications & Media Relations
Kendra Kimmons
Chief People Officer
Mr. Adam Holton
Show Less

See Also

Discover More
What is the Intrinsic Value of one AMED stock?

The intrinsic value of one AMED stock under the Base Case scenario is 103.314 USD.

Is AMED stock undervalued or overvalued?

Compared to the current market price of 91.645 USD, Amedisys Inc is Undervalued by 11%.